{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
A. K.  Nangia, ?Education with a purpose?, Current Science, vol. 115, no. 1, pp. 20-21, 2018.\par \par A.  Lodagekar, Chavan, R. B., Mannava, M. K. Chaitan, Yadav, B., Chella, N., Nangia, A. K., and Shastri, N. R., ?Co amorphous valsartan nifedipine system: Preparation, characterization, in vitro and in vivo evaluation?, European Journal of Pharmaceutical Sciences, vol. 139, 2019.\par \par A. K.  Nangia and Desiraju, G. R., ?Crystal engineering: an outlook for the future?, Angewandte Chemie-International Edition, vol. 58, no. 13, pp. 4100-4107, 2019.\par \par B.  Yadav, Gunnam, A., Thipparaboina, R., Nangia, A. K., and Shastri, N. R., ?Hepatoprotective cocrystals of isoniazid: synthesis, solid state characterization, and hepatotoxicity studies?, Crystal Growth & Design, vol. 19, no. 09, pp. 5161-5172, 2019.\par \par A.  Gunnam and Nangia, A. K., ?High-solubility salts of the multiple sclerosis drug teriflunomide?, Crystal Growth & Design, vol. 19, no. 09, pp.  5407-5417, 2019.\par \par S.  Modani, Gunnam, A., Yadav, B., Nangia, A. K., and Shastri, N. R., ?Generation and evaluation of pharmacologically relevant drug-drug cocrystal for gout therapy?, Crystal Growth & Design, vol. 20, no. 6, pp. 3577-3583, 2020.\par \par S. K.  Rai, Gunnam, A., Mannava, M. K. Chaitan, and Nangia, A. K., ?Improving the dissolution rate of the anticancer drug dabrafenib?, Crystal Growth & Design, vol. 20, no. 2, pp. 1035-1046, 2020.\par \par M. K. Chaitan Mannava, Dandela, R., Tothadi, S., K. Solomon, A., and Nangia, A. K., ?Naftopidil molecular salts with improved dissolution and permeation?, Crystal Growth & Design, vol. 20, no. 5, pp. 3064-3076, 2020.\par \par S.  Allu, Bolla, G., Tothadi, S., and Nangia, A. K., ?Novel pharmaceutical cocrystals and salts of bumetanide?, Crystal Growth & Design, vol. 20, no. 2, pp. 793-803, 2020.\par \par S. K.  Rai, Allu, S., and Nangia, A. K., ?Salts and cocrystal of etodolac: advantage of solubility, dissolution, and permeability?, Crystal Growth & Design, vol. 20, no. 7, pp. 4512-4522, 2020.\par \par S.  Tothadi, Shaikh, T. Rafique, Gupta, S., Dandela, R., Vinod, C. P., and Nangia, A. K., ?Can we identify the salt-cocrystal continuum state using XPS??, Crystal Growth & Design, vol. 21, no. 2, pp. 735-747, 2021.\par \par M. K. Chaitan Mannava, Gunnam, A., Lodagekar, A., Shastri, N. R., Nangia, A. K., and K. Solomon, A., ?Enhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation?, Crystengcomm, vol. 23, no. 1, pp. 227-237, 2021.\par \par M. Kumar Bommaka, Mannava, M. K. Chaitan, Rai, S. K., Suresh, K., and Nangia, A. K., ?Entacapone polymorphs: crystal structures, dissolution, permeability, and stability?, Crystal Growth & Design, vol. 21, no. 10, pp. 5573-5585, 2021.\par \par S. K.  Rai, Baidya, D., and Nangia, A. K., ?Salts, solvates and hydrates of the multi-kinase inhibitor drug pazopanib with hydroxybenzoic acids?, Crystengcomm, vol. 23, no. 35, pp. 5994-6011, 2021.\par \par D.  Tomar, Lodagekar, A., Gunnam, A., Allu, S., Chavan, R. B., Tharkar, M., Ajithkumar, T. G., Nangia, A. K., and Shastri, N. R., ?The effects of cis and trans butenedioic acid on the physicochemical behavior of lumefantrine?, Crystengcomm, vol. 24, no. 1, pp. 156-168, 2022.\par \par M. K. Chaitan Mannava, Bommaka, M. K., Dandela, R., K. Solomon, A., and Nangia, A. K., ?Fluorobenzoic acid coformers to improve the solubility and permeability of the BCS class IV drug naftopidil?, Chemical Communications, vol. 58, no. 37, pp. 5582-5585, 2022.\par \par T. R.  Shaikh, George, C. P., Bhukya, P., Shelke, N., Pawar, K., Garai, A., Dandela, R., Gonnade, R. G., and Nangia, A. K., ?Novel crystal forms of Entresto: a supramolecular complex of trisodium sacubitril/valsartan hemi-pentahydrate?, Crystengcomm, vol. 24, no. 42, pp. 7387-7393, 2022.\par \par S.  Allu, Garai, A., Chernyshev, V. V., and Nangia, A. K., ?Synthesis of ternary cocrystals, salts, and hydrates of acefylline with enhanced dissolution and high permeability?, Crystal Growth & Design, vol. 22, no. 7, pp. 4165?4181, 2022.\par \par S. K.  Rai, Gunnam, A., Roy, D., Rajput, R., Kulkarni, K., and Nangia, A. K., ?Cocrystallization of multi-kinase inhibitor pazopanib with fenamic acids: improving dissolution and inhibiting cell migration?, CrystEngComm, vol. 25, no. 39, pp. 5565-5574, 2023.\par \par S. K.  Rai, Marverti, G., Gunnam, A., Allu, S., and Nangia, A. K., ?Dabrafenib-panobinostat salt: improving the dissolution rate and inhibition of BRAF melanoma cells?, ACS Omega, vol. 8, no. 20, pp. 18255-18265, 2023.\par \par T.  Dubey, Sonawane, S. Kishor, Mannava, M. K. Chaitan, Nangia, A. K., Chandrashekar, M., and Chinnathambi, S., ?Inhibitory effect of curcumin-artemisinin co-amorphous on Tau aggregation and Tau phosphorylation?, Colloid and Surfaces B-Biointerfaces, vol. 221, 2023.\par \par S. K.  Rai, Tothadi, S., Arhangelskis, M., George, C. P., Gonnade, R. G., and Nangia, A. K., ?Polymorph II of hydroxyurea 150 years after its first synthesis?, Crystengcomm, vol. 25, no. 18, pp. 2712-2716, 2023.\par \par }